Not just IgG4 antibodies that become predominant in the many-jabbed, but also lesser studied IgG2, researchers find. NIH ...

China has introduced a groundbreaking vaccine booster, reportedly enhancing immune responses to cancer and infections by up ...

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and ...

A study from Adamson University (AdU) is seeking to contribute to cancer immunotherapy in the development of vaccines against ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE) have agreed to dismiss a U.S. patent lawsuit over Pfizers RSV vaccine, ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids. They ...